David Einhorn‘s Greenlight Capital is going long on Brighthouse Financial Inc (NASDAQ: BHF), a life insurance provider in the U.S. with more than $200 billion in total assets. In its Q4 investor letter, the hedge fund discussed its thesis on Brighthouse Financial, saying that the company is “positioned for a very positive inflection in free cash flow and capital returns over 2019-2020.” Let’s take look the fund’s comment.
(3.8x P/E on 2018 estimated adjusted earnings, 29% of book value)
We have never seen a life insurer trading at this kind of valuation in a stable environment unless it has either a reserving problem or a capital problem. We believe BHF has neither. Not only did BHF initiate share repurchases in mid-2018, two full years ahead of schedule, but during an early-December investor call, BHF management revealed that the business is performing much better than expected a year ago. Improving deposit growth, upsized cost-cutting plans and an acceleration of capital returns all combined to raise the outlook for medium and long-term earnings power and capital returns.
Subject to reasonably steady capital markets, the company plans to repurchase $1.5 billion of stock by the end of 2021. At the year-end value, this would be over 40% of the outstanding shares. Normally, good news is met with a positive response. But with BHF, analysts seem to hate the company no matter what management says. As Sandler O’Neill put it in its December 3, 2018 note:
We view the outlook slides and corresponding conference call as disappointing. This was an investor outlook call. We had expected the company would discuss earnings trajectory for the next year (2019) and not three years (2021) out… That the company announced their first outlook call since separation and did not provide actual guidance for 2019, we find to be a distinct negative.
Never mind that the three-year outlook was much better than consensus expectations, as was the implicit 2019 forecast. And, from the “heads I win, tails you lose” school, the analyst added this gem in describing risk from mortality rates:
The long-term profitability of Brighthouse’s life insurance and annuity products rely upon sound assumptions relating to mortality rates. If mortality rates are lower than assumed, Brighthouse may be required to make larger payments under its annuity products than it had otherwise assumed. If mortality rates are higher, then it would have to make higher payments under its life insurance policies than it had otherwise assumed.
It would be funny, except that the stock fell 48% in 2018 despite a raft of good news.
Looking ahead to 2019 and beyond, BHF’s reported earnings should continue to benefit from deposit growth, cost cutting, and shifts in the company’s investment and hedging portfolios. Cash generation should benefit further from the run-off of “establishment” costs (as the company ends its reliance on MetLife overhead support) and from favorable reforms to annuity rules currently under review at the National Association of Insurance Commissioners. While the business remains sensitive to market performance, including equity returns and interest rates, BHF is positioned for a very positive inflection in free cash flow and capital returns over 2019-2020.
Iakov Filimonov/Shutterstock.com
For the fourth quarter ended December 31, 2018, Brighthouse Financial Inc (NASDAQ: BHF) reported net income of around $1.4 billion in, or $12.14 on a per share, compared to net income of $668 million in the same quarter of 2017. Total revenues for the quarter were around $4.03 billion, versus $1.88 billion in 2017.
On the share market, BHF has been performing in the green since the beginning of the year. Year-to-date, the stock is up more than 26%. Whereas, over the past 12 months, the share price has tumbled over 25%. Analysts polled by FactSet have a consensus average rating of ‘HOLD’ and a consensus average price target of $41.57. BHF is currently is trading at $40.13.
Meanwhile, Brighthouse Financial Inc (NASDAQ: BHF) isn’t very popular stock among hedge funds tracked by Insider Monkey. Our database shows that 22 funds held the stock at the end of the third quarter of 2018.
In this piece, we will take a look at ten recent IPOs in micro cap stocks.
There are a variety of benefits and drawbacks to listing a firm’s equity for trading on the stock market. The single biggest benefit of the process called an IPO, is that it allows management to raise large amounts of funds and investors to potentially profit by seeing their existing stakes multiply in value. At the same time, the IPO process also brings in a variety of constraints. Publicly listed companies are subject to corporate financial reporting requirements of the jurisdictions in which their shares trade. At the same time, share prices can be a volatile affair, and while investors stand to gain significantly if their companies are well received by the market, they also risk equally massive losses should the opposite occur.
Warren Buffett never mentions this but he is one of the first hedge fund managers who unlocked the secrets of successful stock market investing. He launched his hedge fund in 1956 with $105,100 in seed capital. Back then they weren’t called hedge funds, they were called “partnerships”. Warren Buffett took 25% of all returns in excess of 6 percent.
For example S&P 500 Index returned 43.4% in 1958. If Warren Buffett’s hedge fund didn’t generate any outperformance (i.e. secretly invested like a closet index fund), Warren Buffett would have pocketed a quarter of the 37.4% excess return. That would have been 9.35% in hedge fund “fees”.
Actually Warren Buffett failed to beat the S&P 500 Index in 1958, returned only 40.9% and pocketed 8.7 percentage of it as “fees”. His investors didn’t mind that he underperformed the market in 1958 because he beat the market by a large margin in 1957. That year Buffett’s hedge fund returned 10.4% and Buffett took only 1.1 percentage points of that as “fees”. S&P 500 Index lost 10.8% in 1957, so Buffett’s investors actually thrilled to beat the market by 20.1 percentage points in 1957.
Between 1957 and 1966 Warren Buffett’s hedge fund returned 23.5% annually after deducting Warren Buffett’s 5.5 percentage point annual fees. S&P 500 Index generated an average annual compounded return of only 9.2% during the same 10-year period. An investor who invested $10,000 in Warren Buffett’s hedge fund at the beginning of 1957 saw his capital turn into $103,000 before fees and $64,100 after fees (this means Warren Buffett made more than $36,000 in fees from this investor).
As you can guess, Warren Buffett’s #1 wealth building strategy is to generate high returns in the 20% to 30% range.
We see several investors trying to strike it rich in options market by risking their entire savings. You can get rich by returning 20% per year and compounding that for several years. Warren Buffett has been investing and compounding for at least 65 years.
So, how did Warren Buffett manage to generate high returns and beat the market?
In a free sample issue of our monthly newsletter we analyzed Warren Buffett’s stock picks covering the 1999-2017 period and identified the best performing stocks in Warren Buffett’s portfolio. This is basically a recipe to generate better returns than Warren Buffett is achieving himself.
You can enter your email below to get our FREE report. In the same report you can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12-24 months. We initially share this idea in October 2018 and the stock already returned more than 150%. We still like this investment.
Free Report Reveals
Warren Buffet's Secret Recipe
Our Price: $199FREE
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
